Treatment Method Patents After Fed. Circ. Vanda Ruling
In Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals,[1] the Federal Circuit analyzed subject matter eligibility under the U.S. Supreme Court's Alice/Mayo framework,[2] as applied to a treatment method claimed in U.S. Patent...To view the full article, register now.
Already a subscriber? Click here to view full article